alofanib
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Alofanib (RPT835, Ruspharmtech LLC) is a novel selective allosteric inhibitor binding to the extracellular domain of FGFR2…
Alofanib (formerly known as RPT835) is a novel allosteric FGFR2 inhibitor with activity in FGFR2-expressing triple-negative…